Cargando…
Rituximab Can Induce Remission in a Patient with Ankylosing Spondylitis Who Failed Anti-TNF-α Agent
Patient: Male, 38 Final Diagnosis: Ankylosing spondylitis Symptoms: Back pain • morning stiffness Medication: — Clinical Procedure: Not applicable Specialty: Rheuamatology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Ankylosing spondylitis (AS) is a chronic inflammatory disease t...
Autores principales: | AlDhaheri, Fahmi, Almteri, Talal, Dwid, Naji, Majdali, Ahd, Janoudi, Nahed, Almoallim, Hani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315003/ https://www.ncbi.nlm.nih.gov/pubmed/28179619 http://dx.doi.org/10.12659/AJCR.900563 |
Ejemplares similares
-
Rheumatoid Arthritis Saudi Database (RASD): Disease Characteristics and Remission Rates in a Tertiary Care Center
por: Almoallim, Hani, et al.
Publicado: (2020) -
A Case of Rituximab Use as an Induction and Maintenance of Remission in ANCA-Associated Vasculitis
por: Awad, Neveen, et al.
Publicado: (2016) -
Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic vasculitis, Henoch–Schönlein purpura, ankylosing spondylitis, and Raynaud’s phenomenon
por: Taha, Rbab, et al.
Publicado: (2017) -
Anti-TNF-α Therapy for Ankylosing Spondylitis
por: Son, Jung-Hwan, et al.
Publicado: (2010) -
TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
por: Orbán, I, et al.
Publicado: (2011)